Spanish Pharma Stock News

On October 29, 2025, Endesa, S.A. confirmed its full-year 2025 earnings guidance, stating it expects net income to reach the upper end of its previously forecast range. This update signals strengthened management confidence in Endesa's financial outlook and operational progress against its strategic targets for the year. Let's examine how Endesa's raised earnings guidance shapes expectations for its long-term profitability and growth outlook. Trump's oil boom is here - pipelines are primed...

Meliá Hotels International recently reported its financial results for the third quarter and nine months ended September 30, 2025, posting increases in sales, revenue, and net income compared to the previous year. An interesting insight from the results is that the company achieved higher net income over the nine-month period despite ongoing pressures related to operating costs and regional exposure. We'll explore how Meliá's ability to deliver steady earnings growth impacts its overall...

Prosegur Compañía de Seguridad, S.A. reported earnings results for the nine months ended September 30, 2025, with sales of €3.67 billion and net income of €82 million, both higher than the previous year. This performance highlights a substantial improvement in profitability, with net income widening more than €29 million compared to the same period last year. We'll explore how Prosegur's significant net income increase bolsters its investment narrative and potential for sustained financial...

Faes Farma, S.A. recently reported its earnings for the nine months ended September 30, 2025, highlighting sales of €440.95 million and revenue of €454 million, both higher than the prior year, while net income decreased to €73.56 million. Despite higher sales and revenue, the company's lower net income reveals a shift in its profit dynamics during this reporting period. We'll explore how the rise in sales alongside a lower net income influences Faes Farma's investment narrative going...

On October 30, 2025, Puig Brands reaffirmed its earnings guidance for the full year, maintaining like-for-like revenue growth expectations in the 6% to 8% range. This steady outlook, confirmed just after its Q3 2025 earnings call, reflects management’s confidence in the underlying momentum of Puig Brands’ business performance. We’ll explore how management’s reaffirmation of growth guidance shapes Puig Brands’ investment narrative and outlook moving into year-end. Explore 27 top quantum...

Repsol reported its third-quarter 2025 results, revealing sales of €13.09 billion and net income of €574 million, compared to €13.60 billion and €166 million a year earlier. This sharp increase in quarterly profitability came despite slightly lower sales, highlighting a change in Repsol's earnings profile for the period. We will explore how the strong rise in quarterly net income factors into Repsol's overall investment outlook and future earnings trajectory. The end of cancer? These 29...

On October 31, 2025, Mapfre, S.A. reported its earnings for the nine months ended September 30, 2025, posting net income of €829 million, up from €653.5 million a year earlier. This marks a considerable improvement in profitability, reflecting effective cost controls and potentially stronger underwriting across key insurance segments. Next, we’ll assess how Mapfre’s increased net income provides new context for its investment outlook and long-term growth drivers. Outshine the giants: these...

Almirall (BME:ALM) shares have moved slightly higher in the past day, drawing interest from investors curious about recent trading activity and what may be driving sentiment for the Spanish pharmaceutical company. Recent performance trends suggest a mix of caution and optimism. See our latest analysis for Almirall. Almirall’s latest 1.9% share price bump comes after a strong few months, building momentum on a year-to-date price return of nearly 41%. For long-term holders, the total...

Ebro Foods (BME:EBRO) has attracted attention following a recent shift in its stock performance over the past month. This development is sparking interest among investors who are weighing potential upside against recent returns. The company's steady strategy remains a key discussion point. See our latest analysis for Ebro Foods. While Ebro Foods’ share price slipped slightly in the past day, it still posts an 11.4% gain year-to-date and a total shareholder return of 13.7% over the last year...

Amadeus IT Group (BME:AMS) delivered third-quarter earnings that topped expectations, with both revenue and profit coming in ahead of consensus. The company’s outperformance was supported by stronger travel bookings and consistent growth across key markets. See our latest analysis for Amadeus IT Group. After a solid earnings beat and upbeat guidance, Amadeus IT Group's share price has shown only modest movement this year. The 1-year total shareholder return stands just below flat, reflecting...

Amadeus IT Group reported its third quarter and nine-month 2025 financial results, showing year-over-year growth in sales to €1.63 billion and net income to €360.8 million for the quarter ended September 30, 2025. This ongoing growth in both sales and earnings reflects operational momentum and continued market demand for Amadeus's services across its business lines. With third quarter net income up from a year ago, we'll examine how this earnings update further impacts Amadeus IT Group's...

It's been a mediocre week for Laboratorios Farmaceuticos Rovi, S.A. ( BME:ROVI ) shareholders, with the stock dropping...

With its stock down 3.3% over the past month, it is easy to disregard Cementos Molins (BDM:CMO). However, stock prices...

On November 4, 2025, Telefónica announced third quarter 2025 earnings and updated its dividend policy, confirming a proposed €0.15 per share cash dividend for 2026 and outlining a new payout framework tied to free cash flow for 2027 and 2028. This combination of financial disclosure and future dividend guidance has drawn heightened investor interest, particularly as the company signals a renewed focus on capital returns alongside operational performance. We'll now examine how Telefónica's...

The market for Repsol, S.A.'s ( BME:REP ) shares didn't move much after it posted weak earnings recently. We did some...

Gestamp Automoción (BME:GEST) reported a net profit margin of 1.4%, slightly below last year’s 1.5%, following a year of negative earnings growth despite averaging a robust 25.2% annual improvement in profitability over the past five years. The stock currently trades at €2.87, which is well below its estimated fair value of €5.84. A price-to-earnings ratio of 9.8x sets it apart as attractively valued compared to industry benchmarks. Looking ahead, investors will be watching the company’s...

Wondering if Banco Bilbao Vizcaya Argentaria’s impressive run means it's undervalued, fairly priced, or starting to look expensive? Let’s get right to the numbers and clear up the mystery behind the stock’s recent appeal. Shares have been climbing rapidly, with a 3.8% jump in the last week, 11.7% over the past month, and a massive 101.0% total return for shareholders in just the past year alone. Behind these moves are a wave of positive headlines, including successful expansion efforts in...

Wondering whether Grifols could be a bargain or a value trap? You're not alone, and the answer might surprise even seasoned investors. Its share price has swung sharply in recent months, dropping 6.0% over the past week and 11.2% during the last month, but still showing a 13.6% gain so far this year. Headlines have been buzzing around Grifols as investors react to ongoing debates over the company's balance sheet and strategic moves in the plasma sector, which have fueled both optimism and...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Wondering if Banco Santander is a hidden gem or priced to perfection? Let’s dive into what’s driving that curiosity for value-focused investors. The stock has soared an impressive 106.2% over the last year, with a staggering 356.0% gain over five years, hinting at big shifts in market sentiment and possible growth ahead. Recent headlines have put Banco Santander in the spotlight as expansion efforts and digital banking initiatives in Latin America make waves with investors. News about...

Telefónica (BME:TEF) faces headwinds with revenue forecast to decline at 1.3% per year for the next three years, while losses have widened over the last five years at a rate of 55.4% per year. Analysts, however, are projecting a turnaround with profitability expected within the next three years and earnings growth predicted at a robust 59.92% per year. Despite current unprofitability, Telefónica’s price-to-sales ratio of 0.5x positions the stock well below both peer and industry averages,...

As the European market experiences mixed performance, with the pan-European STOXX Europe 600 Index slightly declining after reaching a new high, investors are closely watching interest rate decisions and inflation trends. Amid these dynamics, dividend stocks present an attractive option for those seeking steady income, especially when considering their potential resilience in fluctuating economic conditions.

Gestamp Automoción, S.A. ( BME:GEST ), might not be a large cap stock, but it received a lot of attention from a...